{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T01:51:46Z","timestamp":1782611506553,"version":"3.54.5"},"reference-count":36,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013500","name":"Diabetestutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100013500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2025,8,25]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Poorly controlled type 1 diabetes (T1D) has been associated with impaired bone health, but the mechanisms remain unclear. We aimed to investigate whether changes in glycemic control and glucose variability are associated with skeletal health and to evaluate the roles of insulin-like growth factor I (IGF-I) and advanced glycation end-products (AGEs) in bone mineral accrual.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>This longitudinal study included adolescents with poorly controlled T1D (HbA1c &gt;9%\/75\u2009mmol\/mol), who underwent dual-energy X-ray absorptiometry (DXA) at baseline and after 12 months. Glycemic control was assessed using glycohemoglobin (HbA1c), continuous glucose monitoring (CGM) parameters, and glycemic load. Serum IGF-I and AGEs, specifically methyl-glyoxal-hydro-imidazolone (MG-HI), were measured. Correlation analyses and linear regression models were used to evaluate the associations between glycemic markers, IGF-I, AGEs and bone parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Altogether, 37 adolescents (48.6\u2009% female) with T1D, with mean HbA1c 9.9% (85\u2009mmol\/mol), were followed up from mean age of 14.3 for 12 months. DXA-derived bone mineral density (BMD) z-scores at lumbar spine, proximal femur, and total body less head were approximately 0.5 SDS lower than reference values (p=0.005\u20130.04). The only significant change in BMD z-scores during the 12-month follow-up was an increase in proximal femur in girls. In the whole group, an increase in IGF-1 was associated with BMD accrual, while changes in HbA1c, time in range, or MG-HI were not. No vertebral fractures were detected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Despite lower BMD in adolescents with poorly controlled T1D, neither changes in glycemic control nor MG-HI levels correlated significantly with bone health measures, while increase of IGF-1 was associated with BMD accrual. Future studies should explore alternative AGEs and use advanced bone imaging techniques to better understand skeletal fragility in T1D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005134","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:01:11Z","timestamp":1759928471000},"page":"e005134","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Skeletal health in adolescents with poorly controlled type 1 diabetes: results from a randomized controlled trial"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct02637154","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-1046","authenticated-orcid":false,"given":"Mari-Anne","family":"Pulkkinen","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Uusimaa, Finland"},{"name":"Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-4563","authenticated-orcid":false,"given":"Tero","family":"Varimo","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Uusimaa, Finland"},{"name":"Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Toiviainen-Salo","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taina H","family":"H\u00e4rk\u00f6nen","sequence":"additional","affiliation":[{"name":"Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saila","family":"Laakso","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Uusimaa, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-188X","authenticated-orcid":false,"given":"Anna-Kaisa","family":"Tuomaala","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Uusimaa, Finland"},{"name":"Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Hero","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"2025091421450714000_13.5.e005134.1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.193"},{"key":"2025091421450714000_13.5.e005134.2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1052"},{"key":"2025091421450714000_13.5.e005134.3","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.8.1974"},{"key":"2025091421450714000_13.5.e005134.4","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.1.77"},{"key":"2025091421450714000_13.5.e005134.5","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.118887"},{"key":"2025091421450714000_13.5.e005134.6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MED.0000000000000421","article-title":"Bone health in type 1 diabetes","volume":"25","author":"Shah","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2025091421450714000_13.5.e005134.7","doi-asserted-by":"crossref","unstructured":"Wang H , Ba Y , Xing Q , et al . Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open 2019;9. doi:10.1136\/bmjopen-2018-024067","DOI":"10.1136\/bmjopen-2018-024067"},{"key":"2025091421450714000_13.5.e005134.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2163"},{"key":"2025091421450714000_13.5.e005134.9","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.8.680"},{"key":"2025091421450714000_13.5.e005134.10","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12195"},{"key":"2025091421450714000_13.5.e005134.11","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0019"},{"key":"2025091421450714000_13.5.e005134.12","doi-asserted-by":"crossref","first-page":"639507","DOI":"10.3389\/fendo.2021.639507","article-title":"Motivational interviewing and glycemic control in adolescents with poorly controlled type 1 diabetes: a randomized controlled pilot trial","volume":"12","author":"Tuomaala","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025091421450714000_13.5.e005134.13","doi-asserted-by":"crossref","unstructured":"Pulkkinen M-A , Tuomaala A-K , Hero M , et al . Motivational Interview to improve vascular health in adolescents with poorly controlled type 1 Diabetes (MIAD): a randomized controlled trial. BMJ Open Diabetes Res Care 2020;8. doi:10.1136\/bmjdrc-2020\u2013001216","DOI":"10.1136\/bmjdrc-2020-001216"},{"key":"2025091421450714000_13.5.e005134.14","doi-asserted-by":"crossref","first-page":"e1648","DOI":"10.1210\/clinem\/dgz221","article-title":"Elevated HbA1c is associated with altered cortical and trabecular microarchitecture in girls with type 1 diabetes","volume":"105","author":"Mitchell","year":"2020","journal-title":"JCEM"},{"key":"2025091421450714000_13.5.e005134.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2013.09.004"},{"key":"2025091421450714000_13.5.e005134.16","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2002.016"},{"key":"2025091421450714000_13.5.e005134.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3059"},{"key":"2025091421450714000_13.5.e005134.18","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.515603"},{"key":"2025091421450714000_13.5.e005134.19","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600"},{"key":"2025091421450714000_13.5.e005134.20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.097642"},{"key":"2025091421450714000_13.5.e005134.21","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650080915"},{"key":"2025091421450714000_13.5.e005134.22","first-page":"S28","volume-title":"Pediatr Diabetes","volume":"20","author":"Nurmi-Lawton","year":"2019"},{"key":"2025091421450714000_13.5.e005134.23","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-3128"},{"key":"2025091421450714000_13.5.e005134.24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00198-020-05344-w","article-title":"Incidence of fractures in patients with type 1 diabetes mellitus-a retrospective study with 4420 patients","volume":"31","author":"Stumpf","year":"2020","journal-title":"Osteoporos Int"},{"key":"2025091421450714000_13.5.e005134.25","doi-asserted-by":"crossref","unstructured":"Rasmussen NH , Driessen JHM , Kvist AV , et al . Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: findings from a nationwide retrospective cohort study. Bone 2024;180. doi:10.1016\/j.bone.2023.116997","DOI":"10.1016\/j.bone.2023.116997"},{"key":"2025091421450714000_13.5.e005134.26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025091421450714000_13.5.e005134.27","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081255"},{"key":"2025091421450714000_13.5.e005134.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6603(08)60894-6"},{"key":"2025091421450714000_13.5.e005134.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3422-5"},{"key":"2025091421450714000_13.5.e005134.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2017.04.003"},{"key":"2025091421450714000_13.5.e005134.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-016-0332-1"},{"key":"2025091421450714000_13.5.e005134.32","doi-asserted-by":"crossref","unstructured":"Willett TL , Voziyan P , Nyman JS . Causative or associative: a critical review of the role of advanced glycation end-products in bone fragility. Bone 2022;163. doi:10.1016\/j.bone.2022.116485","DOI":"10.1016\/j.bone.2022.116485"},{"key":"2025091421450714000_13.5.e005134.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2631-7"},{"key":"2025091421450714000_13.5.e005134.34","doi-asserted-by":"crossref","unstructured":"Brandt IAG , Jessen MH , Rimestad DE , et al . Advanced glycation end products and bone - How do we measure them and how do they correlate with bone mineral density and fractures? A systematic review and evaluation of precision of measures. Bone 2022;165. doi:10.1016\/j.bone.2022.116569","DOI":"10.1016\/j.bone.2022.116569"},{"key":"2025091421450714000_13.5.e005134.35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.18388\/abp.2017_1627","article-title":"Relation of the protein glycation, oxidation and nitration to the osteocalcin level in obese subjects","volume":"64","author":"Razny","year":"2017","journal-title":"Acta Biochim Pol"},{"key":"2025091421450714000_13.5.e005134.36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1056-8727(02)00183-6","article-title":"Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes","volume":"17","author":"Miura","year":"2003","journal-title":"J Diabetes Complicat"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:01:14Z","timestamp":1759928474000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,14]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjdrc-2025-005134"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005134","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}